<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">usfd</journal-id><journal-title-group><journal-title xml:lang="ru">Ультразвуковая и функциональная диагностика</journal-title><trans-title-group xml:lang="en"><trans-title>Ultrasound &amp; Functional Diagnostics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0771</issn><issn pub-type="epub">2408-9494</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0771-359</article-id><article-id custom-type="elpub" pub-id-type="custom">usfd-359</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Другие вопросы ультразвуковой диагностики</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Other trends in ultrasound diagnostics</subject></subj-group></article-categories><title-group><article-title>Роль мультипараметрического высокочастотного ультразвукового исследования базально-клеточного рака кожи при проведении фотодинамической терапии</article-title><trans-title-group xml:lang="en"><trans-title>The Role of Multiparametric High-Frequency Ultrasound of Basal Cell Carcinoma in Photodynamic Therapy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-5495-6435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркина</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Markina</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркина Наталья Юрьевна – канд. мед. наук, заведующая отделением ультразвуковой диагностики, врач ультразвуковой диагностики ФГБУ “Центральная клиническая больница с поликлиникой” Управления делами Президента Российской Федерации;доцент кафедры лучевой диагностики и терапии ФГБУ ДПО “Центральная государственная медицинская академия” Управления делами Президента Российской Федерации, Москва<ext-link xlink:href="https://orcid.org/0009-0004-5495-6435" ext-link-type="uri">https://orcid.org/0009-0004-5495-6435</ext-link></p></bio><bio xml:lang="en"><p>Natalia Yu. Markina – MD, PhD (Med.), Head of the Ultrasound Diagnostics Department, Central Clinical Hospital of the Presidential Administration of the Russian Federation;Associate Professor of the Department of Radiation Diagnostics and Therapy, Central State Medical Academy of the Presidential Administration of the Russian Federation, Moscow<ext-link xlink:href="https://orcid.org/0009-0004-5495-6435" ext-link-type="uri">https://orcid.org/0009-0004-5495-6435</ext-link></p></bio><email xlink:type="simple">zykov.msk@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-5687-2155</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zykov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зыков Артём Аркадьевич – врач-онколог отделения торакоабдоминальной онкологии (с кабинетом фотодинамической терапии) ФГБОУ ВО “Российский университет медицины” Минздрава России, Москва<ext-link xlink:href="https://orcid.org/0009-0004-5687-2155" ext-link-type="uri">https://orcid.org/0009-0004-5687-2155</ext-link></p></bio><bio xml:lang="en"><p>Artyom A. Zykov – MD, Oncologist, Thoracoabdominal Oncology department (with Photodynamic Therapy Unit), Central Clinical Hospital of the Presidential Administration of the Russian Federation, Moscow<ext-link xlink:href="https://orcid.org/0009-0004-5687-2155" ext-link-type="uri">https://orcid.org/0009-0004-5687-2155</ext-link></p></bio><email xlink:type="simple">zykov.msk@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-2955-5402</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Словоходов</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Slovokhodov</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Словоходов Егор Константинович – канд. мед. наук, ассистент кафедры паллиативной медицины ФГБОУ ВО “Российский университет медицины” Минздрава России; врач-онколог кабинета фотодинамической терапии ФГБУ “Центральная клиническая больница с поликлиникой” Управления делами Президента Российской Федерации, Москва<ext-link xlink:href="https://orcid.org/0009-0004-2955-5402" ext-link-type="uri">https://orcid.org/0009-0004-2955-5402</ext-link></p></bio><bio xml:lang="en"><p>Egor K. Slovokhodov – MD, PhD (Med.), Assistant Professor of the Department of Palliative Medicine, The Russian University of Medicine of the Ministry of Healthcare of the Russian Federation; Oncologist, Photodynamic Therapy Unit, Central Clinical Hospital of the Presidential Administration of the Russian Federation, Moscow<ext-link xlink:href="https://orcid.org/0009-0004-2955-5402" ext-link-type="uri">https://orcid.org/0009-0004-2955-5402</ext-link></p></bio><email xlink:type="simple">yslovok@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Центральная клиническая больница с поликлиникой” Управления делами Президента Российской Федерации; &#13;
ФГБУ ДПО “Центральная государственная медицинская академия” Управления делами Президента Российской Федерации</institution></aff><aff xml:lang="en"><institution>Central Clinical Hospital of the Presidential Administration of the Russian Federation; &#13;
Central State Medical Academy of the Presidential Administration of the Russian Federation</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ “Центральная клиническая больница с поликлиникой” Управления делами Президента Российской Федерации;&#13;
ФГБОУ ВО “Российский университет медицины” Минздрава России</institution></aff><aff xml:lang="en"><institution>Central Clinical Hospital of the Presidential Administration of the Russian Federation</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ “Центральная клиническая больница с поликлиникой” Управления делами Президента Российской Федерации</institution></aff><aff xml:lang="en"><institution>Central Clinical Hospital of the Presidential Administration of the Russian Federation; &#13;
The Russian University of Medicine of the Ministry of Healthcare of the Russian Federation</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>09</day><month>06</month><year>2026</year></pub-date><volume>32</volume><issue>2</issue><fpage>72</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Маркина Н.Ю., Зыков А.А., Словоходов Е.К., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Маркина Н.Ю., Зыков А.А., Словоходов Е.К.</copyright-holder><copyright-holder xml:lang="en">Markina N.Y., Zykov A.A., Slovokhodov E.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://usfd.rdsmedia.ru/jour/article/view/359">https://usfd.rdsmedia.ru/jour/article/view/359</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: оценить возможности мультипараметрического ультразвукового исследования с использованием высокочастотных датчиков (18–24 МГц) для мониторинга ранних изменений после фотодинамической терапии (ФДТ) у пациентов с базально-клеточным раком кожи (БКРК).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В проспективное одноцентровое исследование включен 31 пациент с 51 гистологически верифицированным очагом БКРК. Всем пациентам выполняли мультипараметрическое ультразвуковое исследование на ультразвуковом сканере Aplio i800 (Canon, Япония) c линейными датчиками частотой 18–24 МГц до и через 24 ч после сеанса ФДТ. Протокол включал оценку образования в B-режиме, в режимах допплеровского и энергетического картирования, в том числе с оценкой микрокровотока (ADF и SMI) с расчетом VI, при компрессионной эластографии и при флуоресцентной спектрометрии.</p></sec><sec><title>Результаты</title><p>Результаты. До лечения все опухоли визуализировались в коже как гипоэхогенные образования с четкими контурами, средней толщиной 3,7 ± 1,2 мм, неоднородной солидной структуры, с выраженной васкуляризацией (VI 32,4 ± 4,1). Через 24 ч после ФДТ зафиксировано статистически значимое снижение VI до 4,2 ± 1,8 (p &lt; 0,001). В B-режиме отмечены увеличение толщины опухоли до 4,4 ± 1,3 мм, снижение четкости контуров и признаки перифокального отека. Флуоресцентная контрастность снизилась с 1:4 до 1:1. Эластографические показатели не продемонстрировали значимой динамики в ранние сроки.</p></sec><sec><title>Заключение</title><p>Заключение. Мультипараметрическое ультразвуковое исследование с высокочастотными датчиками (18–24 МГц) является информативным неинвазивным методом раннего контроля эффективности ФДТ. Наиболее значимым ультразвуковым маркером ответа на лечение служит выраженное снижение интратуморального кровотока, количественно оцениваемое с помощью микродопплеровских методик, что обусловлено ведущим механизмом действия ФДТ – фотохимическим повреждением сосудов микроциркуляторного русла опухоли и развитием коагуляционного некроза.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: To evaluate the potential of multiparametric high-frequency ultrasound (18–24 MHz) for monitoring early changes after photodynamic therapy (PDT) in patients with basal cell carcinoma (BCC).</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. The prospective, single-center study included 31 patients with 51 histologically confirmed basal cell carcinoma lesions. All patients underwent multiparametric ultrasound imaging using an Aplio i800 ultrasound scanner (Canon, Japan) with 18–24 MHz linear transducers before and 24 hours after the PDT session. The protocol included evaluation of the tumor using B-mode, Doppler, and power Doppler mapping, including microcirculation (ADF and SMI) assessment with VI calculation, strain elastography, and fluorescence spectrometry.</p></sec><sec><title>Results</title><p>Results. Before treatment, all cutaneous lesions were presented as hypoechoic lesions with clear margins, an average thickness of 3.7 ± 1.2 mm, a heterogeneous solid structure, and hypervascularisation (VI 32.4 ± 4.1). 24-hours after PDT, a statistically significant decrease in VI to 4.2 ± 1.8 (p &lt; 0.001) was observed. B-mode revealed an increase in tumor thickness to 4.4 ± 1.3 mm, decreased marginal clarity, and signs of perifocal edema. Fluorescence contrast decreased from 1:4 to 1:1. Elastography did not show significant changes in the early stages.</p></sec><sec><title>Conclusion</title><p>Conclusion. Multiparametric ultrasound with high-frequency transducers (18–24 MHz) is an informative, noninvasive method for early monitoring of PDT efficacy. The most significant ultrasound feature of treatment response is a significant reduction in intratumoral blood flow, quantified using micro-Doppler techniques. This is due to the primary mechanism of PDT action –photochemical damage to tumor microvasculature and the development of coagulative necrosis. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мультипараметрическое ультразвуковое исследование</kwd><kwd>фотодинамическая терапия</kwd><kwd>высокочастотный датчик</kwd><kwd>микродопплеровское картирование</kwd><kwd>эластография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiparametric ultrasound</kwd><kwd>photodynamic therapy</kwd><kwd>high-frequency transducer</kwd><kwd>micro-Doppler mapping</kwd><kwd>elastography</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">нет</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Peris K., Fargnoli M.C., Garbe C. et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur. J. Cancer. 2019; 118: 10–34. https://doi.org/10.1016/j.ejca.2019.06.003</mixed-citation><mixed-citation xml:lang="en">Peris K., Fargnoli M.C., Garbe C. et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur. J. Cancer. 2019; 118: 10–34. https://doi.org/10.1016/j.ejca.2019.06.003</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Morton C.A., Szeimies R.M., Basset-Seguin N. et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratosis, Bowen's disease and basal cell carcinomas. J. Eur. Acad. Dermatol. Venereol. 2019; 33 (12): 2225–2238. https://doi.org/10.1111/jdv.16017</mixed-citation><mixed-citation xml:lang="en">Morton C.A., Szeimies R.M., Basset-Seguin N. et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratosis, Bowen's disease and basal cell carcinomas. J. Eur. Acad. Dermatol. Venereol. 2019; 33 (12): 2225–2238. https://doi.org/10.1111/jdv.16017</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Agostinis P., Berg K., Cengel K.A. et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 2011; 61 (4): 250–281. https://doi.org/10.3322/caac.20114</mixed-citation><mixed-citation xml:lang="en">Agostinis P., Berg K., Cengel K.A. et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 2011; 61 (4): 250–281. https://doi.org/10.3322/caac.20114</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wortsman X. Ultrasound in Skin Cancer: Why, How, and When to Use It? Cancers. 2024; 16 (19): 3301. https://doi.org/10.3390/cancers16193301</mixed-citation><mixed-citation xml:lang="en">Wortsman X. Ultrasound in Skin Cancer: Why, How, and When to Use It? Cancers. 2024; 16 (19): 3301. https://doi.org/10.3390/cancers16193301</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Crisan D., Tarnowietzki E., Bernhard L. et al. Rationale for Using High-Frequency Ultrasound as a Routine Examination in Skin Cancer Surgery: A Practical Approach. J. Clin. Med. 2024; 13 (7): 2152. https://doi.org/10.3390/jcm13072152</mixed-citation><mixed-citation xml:lang="en">Crisan D., Tarnowietzki E., Bernhard L. et al. Rationale for Using High-Frequency Ultrasound as a Routine Examination in Skin Cancer Surgery: A Practical Approach. J. Clin. Med. 2024; 13 (7): 2152. https://doi.org/10.3390/jcm13072152</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Austin E., Wang J.Y., Ozog D.M. et al. Photodynamic Therapy: Overview and Mechanism of Action. J. Am. Acad. Dermatol. 2025: S0190-9622(25)00321-4. https://doi.org/10.1016/j.jaad.2025.02.037</mixed-citation><mixed-citation xml:lang="en">Austin E., Wang J.Y., Ozog D.M. et al. Photodynamic Therapy: Overview and Mechanism of Action. J. Am. Acad. Dermatol. 2025: S0190-9622(25)00321-4. https://doi.org/10.1016/j.jaad.2025.02.037</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J.Y., Zeitouni N., Austin E. et al. Photodynamic Therapy: Clinical Applications in Dermatology. J. Am. Acad. Dermatol. 2025: S0190-9622(25)00322-6. https://doi.org/10.1016/j.jaad.2024.12.050</mixed-citation><mixed-citation xml:lang="en">Wang J.Y., Zeitouni N., Austin E. et al. Photodynamic Therapy: Clinical Applications in Dermatology. J. Am. Acad. Dermatol. 2025: S0190-9622(25)00322-6. https://doi.org/10.1016/j.jaad.2024.12.050</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Canti G., De Simone A., Korbelik M. Photodynamic therapy and the immune system in experimental oncology. Photochem. Photobiol. Sci. 2002; 1 (1): 79–80. https://doi.org/10.1039/b107764g</mixed-citation><mixed-citation xml:lang="en">Canti G., De Simone A., Korbelik M. Photodynamic therapy and the immune system in experimental oncology. Photochem. Photobiol. Sci. 2002; 1 (1): 79–80. https://doi.org/10.1039/b107764g</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Płocka M., Czajkowski R. High-frequency ultrasound in the diagnosis and treatment of skin neoplasms. Postepy Dermatol. Alergol. 2023; 40 (2): 204–207. https://doi.org/10.5114/ada.2023.127638</mixed-citation><mixed-citation xml:lang="en">Płocka M., Czajkowski R. High-frequency ultrasound in the diagnosis and treatment of skin neoplasms. Postepy Dermatol. Alergol. 2023; 40 (2): 204–207. https://doi.org/10.5114/ada.2023.127638</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Boostani M., Wortsman X., Pellacani G. et al. Dermoscopy-guided high-frequency ultrasound for preoperative assessment of basal cell carcinoma lateral margins: a pilot study. Br. J. Dermatol. 2025; 193 (3): 572–574. https://doi.org/10.1093/bjd/ljaf209</mixed-citation><mixed-citation xml:lang="en">Boostani M., Wortsman X., Pellacani G. et al. Dermoscopy-guided high-frequency ultrasound for preoperative assessment of basal cell carcinoma lateral margins: a pilot study. Br. J. Dermatol. 2025; 193 (3): 572–574. https://doi.org/10.1093/bjd/ljaf209</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Szalai K., Tóth K., Hársing J. et al. High-Frequency Ultrasound Assessment of Basal Cell Carcinoma: Correlations Between Histopathological Subtype, Vascularity, and Age/Sex Distribution. Cancers (Basel). 2026; 18 (2): 274. https://doi.org/10.3390/cancers18020274</mixed-citation><mixed-citation xml:lang="en">Szalai K., Tóth K., Hársing J. et al. High-Frequency Ultrasound Assessment of Basal Cell Carcinoma: Correlations Between Histopathological Subtype, Vascularity, and Age/Sex Distribution. Cancers (Basel). 2026; 18 (2): 274. https://doi.org/10.3390/cancers18020274</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Feng M.C., Liang J.F., Chen Y.X. et al. Construction of an Aggressiveness Diagnostic Model for Basal Cell Carcinoma Using Multimodal Ultrasound Features. J. Ultrasound Med. 2025; 44 (10): 1839–1848. https://doi.org/10.1002/jum</mixed-citation><mixed-citation xml:lang="en">Feng M.C., Liang J.F., Chen Y.X. et al. Construction of an Aggressiveness Diagnostic Model for Basal Cell Carcinoma Using Multimodal Ultrasound Features. J. Ultrasound Med. 2025; 44 (10): 1839–1848. https://doi.org/10.1002/jum</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
